Today: 3 May 2026
IBM stock price today: Shares slip as Fed minutes loom in thin year-end trade
30 December 2025
2 mins read

IBM stock price today: Shares slip as Fed minutes loom in thin year-end trade

NEW YORK, December 30, 2025, 11:30 ET — Regular session

  • IBM shares down about 0.5% in late morning trade, hovering near the $300 level.
  • Investors await the Fed’s meeting minutes due at 2 p.m. ET for clues on the 2026 rate path.
  • An SEC filing showed a director amended a prior insider report tied to deferred board fees.

International Business Machines (IBM.N) shares slipped about 0.5% on Tuesday. At 11:15 a.m. ET, the stock was down $1.63 at $304.11, after trading between $302.73 and $306.24 and opening at $306.15. Volume was about 462,000 shares.

The move matters now because year-end trading is typically thin, and modest shifts in risk appetite can push large-cap names around. For IBM, the market’s view on interest rates also feeds into how investors price steady, cash-generating tech stocks.

Investors were awaiting the Federal Reserve’s meeting minutes — the detailed record of policymakers’ debate — from the Dec. 9-10 gathering, due at 2 p.m. ET. The Fed cut rates by a quarter point to a 3.50%-3.75% range, and the minutes are expected to shed light on divisions over the 2026 policy path.

The S&P 500 and Nasdaq edged lower in light year-end volumes as big tech names retreated for a second day, Reuters reported. “I wouldn’t try to make too much out of anything that happens in a holiday-shortened week and very light trading volume,” said Art Hogan, chief market strategist at B Riley Wealth. Reuters

IBM’s own news flow was quieter, but an amended Form 4 filing — an insider ownership disclosure required by the U.S. SEC — showed director David N. Farr corrected a prior report on deferred board fees. The filing updated the number of “Promised Fee Shares” acquired on June 30 to 200.283 after a prior Form 4 omitted 4.283 shares; promised fee shares are stock units delivered later when directors elect to defer fees into equity rather than cash. SEC

Separately, IBM said former chief executive Louis Gerstner died at 83, with CEO Arvind Krishna announcing the news in an email to employees. Gerstner, credited with steering IBM through a crisis in the 1990s, ran the company from 1993 to 2002.

For traders, the bigger swing factor is still the macro backdrop, with Fed messaging feeding directly into equity risk appetite. IBM often trades as a steadier name inside tech, but it tends to track sector moves when investors pull back from risk.

Technically, IBM remains close to the $300 level that many investors treat as a psychological line in the sand. The day’s low near $303 leaves little room for sentiment to weaken if broader tech selling accelerates.

The next IBM-specific catalyst is its fourth-quarter earnings announcement on Jan. 28, 2026, a preliminary date listed on the company’s investor events calendar. Investors will listen for updates on software demand and consulting signings as customers weigh AI projects against tighter budgets.

IBM has been using dealmaking to build out its cloud and AI stack, and earlier this month it agreed to buy data streaming firm Confluent for $11 billion. The transaction is slated to close by mid-2026, Reuters reported.

Stocks are set for a normal session on New Year’s Eve, but U.S. exchanges will be closed on Jan. 1 for the holiday. With the calendar thinning out, IBM traders are likely to watch the Fed minutes and broad tech sentiment for the next near-term direction.

Stock Market Today

  • Fed Chair Nominee Kevin Warsh Challenges Powell on Fed Balance Sheet Policy Impacting Markets
    May 3, 2026, 4:10 AM EDT. Kevin Warsh, poised to become Federal Reserve chairman, diverges sharply from Jerome Powell on the Fed's use of its balance sheet, a key tool alongside interest rates. While Powell's approach involves buying long-term bonds to influence rates, Warsh advocates shrinking the Fed's $6 trillion securities holdings. This reduction could drive bond prices down, pushing long-term interest rates up, with broad effects on financial markets, including stocks. The move risks market disruption, as seen in 2019 and 2022 when past balance sheet reductions triggered rate spikes. Warsh acknowledges a gradual unwind is needed but warns investors should expect significant market impacts. His stance signals potential shifts in Fed policy strategy amid ongoing political pressure to lower the fed funds rate.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 03.05.2026

3 May 2026
Rivian shares fell 8.4% to $15.02 after first-quarter results beat expectations, as investors focused on cash burn and profitability concerns. Trading volume jumped 78% above average. The company plans to ramp up R2 SUV production in Georgia to 300,000 units annually. Tesla and Lucid Group shares both rose more than 2%.
Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
Eli Lilly stock dips after report flags China price cuts for Mounjaro
Previous Story

Eli Lilly stock dips after report flags China price cuts for Mounjaro

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX
Next Story

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Go toTop